Loading…

The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review

Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (P...

Full description

Saved in:
Bibliographic Details
Published in:Drug design, development and therapy development and therapy, 2020-01, Vol.14, p.1749-1755
Main Authors: Mercuri, S R, Vollono, L, Paolino, G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23
cites cdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23
container_end_page 1755
container_issue
container_start_page 1749
container_title Drug design, development and therapy
container_volume 14
creator Mercuri, S R
Vollono, L
Paolino, G
description Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo. We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo. Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo". We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects. PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo.
doi_str_mv 10.2147/DDDT.S239912
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5d5e2b85babd4bddbbad6629e468d815</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A626928685</galeid><doaj_id>oai_doaj_org_article_5d5e2b85babd4bddbbad6629e468d815</doaj_id><sourcerecordid>A626928685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</originalsourceid><addsrcrecordid>eNptkk1rGzEQhpfS0qRpbz2XhUJJoXYl7a5W20PBxP0IBGocp1ehj5GtoF0lkpzSf19t7QYbig4ajZ73RaOZoniN0ZTguv04n89X02tSdR0mT4pTjNt2whjDTw_ik-JFjLcI0YoS9Lw4qUhdI4zQabFebaC8iWC2boAYS2_KhRMJHKTJ0qrNeIq9KM8Xy8X70vhQpixYBRCphyGN_E-brLNr_6m8Tlk5pkZmFlIpBl0u4cHCr5fFMyNchFf7_ay4-fpldfF9cvXj2-XF7GqimpqlCZatJhSpyhiiMUisiMQNbjoN0LYgKsZyoBhWWKO2kdhQaqhiSFOGkSHVWXG589Ve3PK7YHsRfnMvLP-b8GHNRUhWOeCNboBI1kghdS21llJoSkkHNWWa4SZ7fd553W1lD1rleoNwR6bHN4Pd8LV_4C3BFaOjwfneIPj7LcTEexsVOCcG8NvISZ07gprck4y-3aFrkZ9mB-OzoxpxPqOEdoRRNhpO_0PlpaG3yg9gbM4fCd4dCDYgXNpE77bJ-iEegx92oAo-xgDmsUyM-DhnfJwzvp-zjL85_JpH-N9gVX8AnSLL2w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2406305620</pqid></control><display><type>article</type><title>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Taylor &amp; Francis Open Access</source><source>PubMed Central</source><creator>Mercuri, S R ; Vollono, L ; Paolino, G</creator><creatorcontrib>Mercuri, S R ; Vollono, L ; Paolino, G</creatorcontrib><description>Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo. We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo. Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo". We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects. PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo.</description><identifier>ISSN: 1177-8881</identifier><identifier>EISSN: 1177-8881</identifier><identifier>DOI: 10.2147/DDDT.S239912</identifier><identifier>PMID: 32440100</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Care and treatment ; Dermatologic agents ; Fibrin ; Humans ; Medical research ; Platelet-Rich Plasma ; platlet rich plasma ; prp ; Review ; Skin ; Skin diseases ; treatment ; vitiligo ; Vitiligo - therapy</subject><ispartof>Drug design, development and therapy, 2020-01, Vol.14, p.1749-1755</ispartof><rights>2020 Mercuri et al.</rights><rights>COPYRIGHT 2020 Dove Medical Press Limited</rights><rights>2020 Mercuri et al. 2020 Mercuri et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</citedby><cites>FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</cites><orcidid>0000-0001-8858-9531 ; 0000-0002-3032-2217</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213865/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213865/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32440100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mercuri, S R</creatorcontrib><creatorcontrib>Vollono, L</creatorcontrib><creatorcontrib>Paolino, G</creatorcontrib><title>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</title><title>Drug design, development and therapy</title><addtitle>Drug Des Devel Ther</addtitle><description>Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo. We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo. Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo". We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects. PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo.</description><subject>Care and treatment</subject><subject>Dermatologic agents</subject><subject>Fibrin</subject><subject>Humans</subject><subject>Medical research</subject><subject>Platelet-Rich Plasma</subject><subject>platlet rich plasma</subject><subject>prp</subject><subject>Review</subject><subject>Skin</subject><subject>Skin diseases</subject><subject>treatment</subject><subject>vitiligo</subject><subject>Vitiligo - therapy</subject><issn>1177-8881</issn><issn>1177-8881</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkk1rGzEQhpfS0qRpbz2XhUJJoXYl7a5W20PBxP0IBGocp1ehj5GtoF0lkpzSf19t7QYbig4ajZ73RaOZoniN0ZTguv04n89X02tSdR0mT4pTjNt2whjDTw_ik-JFjLcI0YoS9Lw4qUhdI4zQabFebaC8iWC2boAYS2_KhRMJHKTJ0qrNeIq9KM8Xy8X70vhQpixYBRCphyGN_E-brLNr_6m8Tlk5pkZmFlIpBl0u4cHCr5fFMyNchFf7_ay4-fpldfF9cvXj2-XF7GqimpqlCZatJhSpyhiiMUisiMQNbjoN0LYgKsZyoBhWWKO2kdhQaqhiSFOGkSHVWXG589Ve3PK7YHsRfnMvLP-b8GHNRUhWOeCNboBI1kghdS21llJoSkkHNWWa4SZ7fd553W1lD1rleoNwR6bHN4Pd8LV_4C3BFaOjwfneIPj7LcTEexsVOCcG8NvISZ07gprck4y-3aFrkZ9mB-OzoxpxPqOEdoRRNhpO_0PlpaG3yg9gbM4fCd4dCDYgXNpE77bJ-iEegx92oAo-xgDmsUyM-DhnfJwzvp-zjL85_JpH-N9gVX8AnSLL2w</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Mercuri, S R</creator><creator>Vollono, L</creator><creator>Paolino, G</creator><general>Dove Medical Press Limited</general><general>Dove</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8858-9531</orcidid><orcidid>https://orcid.org/0000-0002-3032-2217</orcidid></search><sort><creationdate>20200101</creationdate><title>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</title><author>Mercuri, S R ; Vollono, L ; Paolino, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Care and treatment</topic><topic>Dermatologic agents</topic><topic>Fibrin</topic><topic>Humans</topic><topic>Medical research</topic><topic>Platelet-Rich Plasma</topic><topic>platlet rich plasma</topic><topic>prp</topic><topic>Review</topic><topic>Skin</topic><topic>Skin diseases</topic><topic>treatment</topic><topic>vitiligo</topic><topic>Vitiligo - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mercuri, S R</creatorcontrib><creatorcontrib>Vollono, L</creatorcontrib><creatorcontrib>Paolino, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Drug design, development and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mercuri, S R</au><au>Vollono, L</au><au>Paolino, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review</atitle><jtitle>Drug design, development and therapy</jtitle><addtitle>Drug Des Devel Ther</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>14</volume><spage>1749</spage><epage>1755</epage><pages>1749-1755</pages><issn>1177-8881</issn><eissn>1177-8881</eissn><abstract>Vitiligo is an acquired, idiopathic disorder clinically characterized by amelanotic lesions on the skin which cause significant impairment of patients' quality of life. A variety of treatments have been proposed, with inconsistent results. In the last decades, the use of platelet-rich plasma (PRP) is receiving increasing interest as a potential effective technique in the treatment of several dermatological diseases, including vitiligo. We conducted a review with the aim to identify studies that documented the use of PRP for vitiligo. Electronic databases of MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) from inception to November 2019 have been searched using different combinations of the following terms: "platelet-rich plasma", "platelet gel", "platelet-rich fibrin", "PRP" and "vitiligo". We identified 6 clinical studies consistent with our research, with a total of 253 patients, listing and discussing the obtained results. In all reports, all treated patients showed a stable vitiligo, and a significantly higher improvement in the PRP groups was always observed compared to control groups. Regarding the side effects, PRP in vitiligo patients is useful and without important side effects. PRP is a promising treatment for stable vitiligo lesions in different body sites. The possible use of PRP in combination with traditional therapeutic options and the standardization of processing protocols represents a very fertile field for future research. Larger clinical trials with longer time of observation would provide solid evidence regarding the effectiveness of PRP for the treatment of vitiligo.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>32440100</pmid><doi>10.2147/DDDT.S239912</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-8858-9531</orcidid><orcidid>https://orcid.org/0000-0002-3032-2217</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1177-8881
ispartof Drug design, development and therapy, 2020-01, Vol.14, p.1749-1755
issn 1177-8881
1177-8881
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_5d5e2b85babd4bddbbad6629e468d815
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); Taylor & Francis Open Access; PubMed Central
subjects Care and treatment
Dermatologic agents
Fibrin
Humans
Medical research
Platelet-Rich Plasma
platlet rich plasma
prp
Review
Skin
Skin diseases
treatment
vitiligo
Vitiligo - therapy
title The Usefulness of Platelet-Rich Plasma (PRP) for the Treatment of Vitiligo: State of the Art and Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A12%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Usefulness%20of%20Platelet-Rich%20Plasma%20(PRP)%20for%20the%20Treatment%20of%20Vitiligo:%20State%20of%20the%20Art%20and%20Review&rft.jtitle=Drug%20design,%20development%20and%20therapy&rft.au=Mercuri,%20S%20R&rft.date=2020-01-01&rft.volume=14&rft.spage=1749&rft.epage=1755&rft.pages=1749-1755&rft.issn=1177-8881&rft.eissn=1177-8881&rft_id=info:doi/10.2147/DDDT.S239912&rft_dat=%3Cgale_doaj_%3EA626928685%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c548t-1b7d260c3ff2d1eb1c2b15159dee77ea388ee7c81c1d075b1f66f6c80d6810f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2406305620&rft_id=info:pmid/32440100&rft_galeid=A626928685&rfr_iscdi=true